Cytek Biosciences, Inc.
CTKB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$6,020 | -$12,148 | $2,484 | $3,027 |
| Dep. & Amort. | $10,490 | $9,230 | $5,659 | $1,242 |
| Deferred Tax | -$2,886 | $0 | $0 | $0 |
| Stock-Based Comp. | $26,848 | $22,048 | $16,595 | $6,586 |
| Change in WC | $7,713 | -$10,509 | -$39,928 | -$8,646 |
| Other Non-Cash | -$10,766 | -$3,340 | $2,959 | $2,421 |
| Operating Cash Flow | $25,379 | $5,281 | -$12,231 | $4,630 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,525 | -$4,648 | -$9,748 | -$4,364 |
| Net Acquisitions | -$471 | -$45,132 | $0 | -$16,629 |
| Inv. Purchases | -$274,062 | -$175,935 | -$46,041 | $0 |
| Inv. Sales/Matur. | $195,000 | $132,000 | $0 | $0 |
| Other Inv. Act. | $84 | -$179 | -$120 | $0 |
| Investing Cash Flow | -$82,974 | -$93,894 | -$55,909 | -$20,993 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $3,624 | -$565 | $2,933 | -$2,772 |
| Stock Issued | $0 | $0 | $0 | $215,689 |
| Stock Repurch. | -$21,611 | -$44,151 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,165 | $2,904 | $2,580 | $642 |
| Financing Cash Flow | -$15,822 | -$41,812 | $5,513 | $213,559 |
| Forex Effect | $4,532 | -$1,445 | -$2,491 | $1,303 |
| Net Chg. in Cash | -$68,885 | -$131,870 | -$65,118 | $198,499 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $167,630 | $299,500 | $364,618 | $166,119 |
| End Cash | $98,745 | $167,630 | $299,500 | $364,618 |
| Free Cash Flow | $21,854 | $454 | -$22,099 | $266 |